INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
FDAs Inspections of Pfizer’s Facility in Belgium, Manufacturing COMRINATY, show life-threatening issues.
Copy link
Facebook
Email
Notes
More

FDAs Inspections of Pfizer’s Facility in Belgium, Manufacturing COMRINATY, show life-threatening issues.

AS YET, NO ACTION HAS BEEN TAKEN BY THE FDA!!!

Hedley Rees's avatar
Hedley Rees
Jun 30, 2024
∙ Paid
34

Share this post

INSIDE PHARMA
INSIDE PHARMA
FDAs Inspections of Pfizer’s Facility in Belgium, Manufacturing COMRINATY, show life-threatening issues.
Copy link
Facebook
Email
Notes
More
25
7
Share

Share

FDAs Inspections of Pfizer’s Manufactruing, Puurs, Belgium Facility:

Today’s post is easy to understand screenshots from FDAs facility inspections database. As I have said previously, the FDA website has always been the world’s best when it comes to open, transparent information available to anyone who knows where to find it. This is the inspection record for Pfizer’s facility in Belgium manufacturing the COMRINATY, BLA 125742 Drug Product (filled & capped vials):

From 2011 to 2023, the site was inspected by FDA six times. If it had been inspected for suitability to manufacture biologics (eg vaccines), the screenshot would show ‘biologics’ under the heading Product Type (last but one column on the right).

IT NEVER WAS INSPECTED BY FDA FOR BIOLOGICS (VACCINE) MANUFACTURE.

However, the 2022 inspection ‘Drug’ inspection is shown as Mutual Recognition. That means it was carried out by another agency, but we don’t know which. Hmmm.

These are the CITATIONS from the inspections:

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More